Ledger.Open graph →
SEC Form D · filed October 15, 2024

IN8BIO, INC

Offering
$12.4M
Sold
$12.4M
Exemption
Rule 506(c)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (12)

R. Brandt · New York, NYExec · DirectorJeremy R. Graff · New York, NYDirectorEmily R. Fairbairn · New York, NYDirectorPatrick Mccall · New York, NYExecLuba R. Greenwood · New York, NYDirectorPeter S. Brandt · New York, NYDirectorTravis R. Whitfill · New York, NYDirectorLawrence R. Lamb · New York, NYExecAlan S. Roemer · New York, NYDirectorWilliam Ho · New York, NYExec · DirectorCorinne R. Epperly · New York, NYDirectorKate R. Rochlin · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗